K. Ckless et al., INHIBITION OF IN-VITRO LYMPHOCYTE-TRANSFORMATION BY THE ISOQUINOLINE ALKALOID BERBERINE, Journal of Pharmacy and Pharmacology, 47(12A), 1995, pp. 1029-1031
Berberine is an isoquinoline alkaloid with multiple pharmacological ac
tions, including an anti-inflammatory activity. The effects of berberi
ne on in-vitro cellular proliferation of human peripheral lymphocytes
stimulated with phytohaemagglutinin, concanavalin A and pokeweed mitog
en were studied. Mononuclear cells were cultured in flat-bottomed 96-w
ell microplates at 37 degrees C for 96-144h in the presence of one mit
ogen at different concentrations and the alkaloid at doses of 2.5 to 2
0 mu gmL(-1). The mitogen-induced response of lymphocytes was evaluate
d from the extent of the incorporation of [H-3]thymidine into cells in
vitro. A consistent and progressive inhibitory influence of berberine
with increasing concentrations in culture was identified with all mit
ogens and was more pronounced with pokeweed mitogen. The effect of ber
berine was observed in phytohaemagglutinin (PHA)- and concanavalin A-a
ctivated lymphocytes when the drug was added during the first 24h of c
ulture, whereas the same effect occurred throughout the incubation per
iod in pokeweed mitogen-stimulated cells. The viability of lymphocytes
following treatment with the drug, as assessed by the trypan blue exc
lusion test, revealed no change when compared with the same untreated
lymphocytes, indicating no lymphocytotoxic activity. We conclude that
some effects of berberine, especially its anti-inflammatory action, ma
y arise in part from the inhibition of DNA-synthesis in activated lymp
hocytes.